Paper12830009
The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.
Moore KP and 12 others. Hepatology, 2003. Cited by 676 papers, by iCite.
Cite this record
ConductScience Library. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Papers, record 12830009. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12830009
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.
- PubMed
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ascites | Major topic |
| Liver Cirrhosis | Major topic |
| Evidence-Based Medicine | |
| Humans |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00986817 | Terlipressin in Cirrhotic Patients With Recidivation Ascites Treated With Paracentesis and Albumin | Background | ClinicalTrials.gov | |
| NCT04043858 | Safety and Efficacy of Midodrine Hydrochloride in the Management of Refractory Ascites Due to Cirrhosis in Children | Background | ClinicalTrials.gov |
Cited by292
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 676 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42902152 | Combined TIPS and TACE for patients with hepatocellular carcinoma and variceal bleeding secondary to portal vein tumor thrombus. | BMC Gastroenterol | 2026 | https://conductscience.org/library/papers/42902152 | PubMed |
| 42581040 | Temperature-sensitive liquid embolic agent transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for BCLC Stage B/C hepatocellular carcinoma: a multicenter real-world study and spatial transcriptomics profiling (CHANCE 2515). | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42581040 | PubMed |
| 42512363 | Exploratory Evaluation of Hepatic Venous Pressure Gradient, Indocyanine Green Retention, and Liver Stiffness in Predicting Short-Term Outcomes After Liver Resection in Patients with Cirrhosis: A Multicenter Prospective Study. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42512363 | PubMed |
| 42435328 | Pre-Treatment Serum Albumin Concentration Predicts Clinical Benefit of Long-Term Albumin in Patients With Cirrhosis and Ascites. | United European Gastroenterol J | 2026 | https://conductscience.org/library/papers/42435328 | PubMed |
| 42218281 | Predictors and outcomes of hepatic decompensation following transarterial locoregional therapy in hepatocellular carcinoma. | Sci Rep | 2026 | https://conductscience.org/library/papers/42218281 | PubMed |
| 42210133 | Extracellular volume fraction derived from spectral CT for liver function reserve evaluation and complication prediction in clinically stable liver cirrhosis. | BMC Med Imaging | 2026 | https://conductscience.org/library/papers/42210133 | PubMed |
| 42058809 | Open-label randomized controlled study of salt-restricted vs salt-unrestricted diet in patients with cirrhosis with hyponatremia. | World J Methodol | 2026 | https://conductscience.org/library/papers/42058809 | PubMed |
| 42050795 | KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications 2026. | Clin Mol Hepatol | 2026 | https://conductscience.org/library/papers/42050795 | PubMed |
| 42022527 | Refractory Ascites and the Alfapump. | Gastro Hep Adv | 2026 | https://conductscience.org/library/papers/42022527 | PubMed |
| 41976936 | Prognostic Relevance of Ascites Volume and Dynamics in Outpatients with Cirrhosis: A Prospective Cohort Study. | J Clin Med | 2026 | https://conductscience.org/library/papers/41976936 | PubMed |
| 41648734 | Real-world outcomes of trifluridine/tipiracil for heavily pretreated patients with advanced gastric cancer. | ESMO Gastrointest Oncol | 2024 | https://conductscience.org/library/papers/41648734 | PubMed |
| 41572027 | Persistent Lymphatic Ascites After Liver Transplantation: Identification of the Underlying Mechanism of Ascites Permits Successful Percutaneous Treatment. | Cardiovasc Intervent Radiol | 2026 | https://conductscience.org/library/papers/41572027 | PubMed |
| 41417961 | TIPS improves survival in patients with cirrhosis and recurrent ascites: a multicenter observational study. | Int J Surg | 2025 | https://conductscience.org/library/papers/41417961 | PubMed |
| 41384215 | Diagnostic and Therapeutic Challenges of Hepatoadrenal Syndrome in Advanced Cirrhosis: A Case Report and Literature Review. | Cureus | 2025 | https://conductscience.org/library/papers/41384215 | PubMed |
| 41379842 | Feasibility study of a novel technique for treating refractory ascites using a peritoneobladder shunt in a swine model. | PLoS One | 2025 | https://conductscience.org/library/papers/41379842 | PubMed |
| 41268036 | Long-Term Abdominal Drains in Refractory Ascites Due to Cirrhosis: A Retrospective Cohort Analysis. | Cureus | 2025 | https://conductscience.org/library/papers/41268036 | PubMed |
| 41213540 | [Position paper for the standardized use of transjugular intrahepatic portosystemic shunt (TIPS) in adults]. | Z Gastroenterol | 2025 | https://conductscience.org/library/papers/41213540 | PubMed |
| 41194902 | Outcomes in Cirrhosis-Related Refractory Ascites with Emphasis on Palliative Care: Single-Centre Experience and Literature Review. | Curr Hepatol Rep | 2024 | https://conductscience.org/library/papers/41194902 | PubMed |
| 41094298 | Splenic artery embolization for refractory ascites after liver transplantation: a single-center experience. | CVIR Endovasc | 2025 | https://conductscience.org/library/papers/41094298 | PubMed |
| 40949845 | Determining the optimal portal pressure gradient after small-diameter TIPS for ascites: a retrospective study. | Ther Adv Gastroenterol | 2025 | https://conductscience.org/library/papers/40949845 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12830009
GET https://conductscience.org/api/papers/v1/12830009/cited_by?page=2